BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

589 related articles for article (PubMed ID: 29627826)

  • 1. Meibomian Gland Dysfunction in Primary and Secondary Sjögren Syndrome.
    Sullivan DA; Dana R; Sullivan RM; Krenzer KL; Sahin A; Arica B; Liu Y; Kam WR; Papas AS; Cermak JM
    Ophthalmic Res; 2018; 59(4):193-205. PubMed ID: 29627826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Manifestation of meibomian gland dysfunction in patients with Sjögren's syndrome, non-Sjögren's dry eye, and non-dry eye controls.
    Kang YS; Lee HS; Li Y; Choi W; Yoon KC
    Int Ophthalmol; 2018 Jun; 38(3):1161-1167. PubMed ID: 28567496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Analysis: Aqueous-Deficient and Meibomian Gland Dysfunction in Patients With Primary Sjogren's Syndrome.
    Wang Y; Qin Q; Liu B; Fu Y; Lin L; Huang X; Jin X
    Front Med (Lausanne); 2019; 6():291. PubMed ID: 31921869
    [No Abstract]   [Full Text] [Related]  

  • 4. Increased Tear Fluid Production as a Compensatory Response to Meibomian Gland Loss: A Multicenter Cross-sectional Study.
    Arita R; Morishige N; Koh S; Shirakawa R; Kawashima M; Sakimoto T; Suzuki T; Tsubota K
    Ophthalmology; 2015 May; 122(5):925-33. PubMed ID: 25626757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meibomian gland dropout in Sjögren's syndrome and non-Sjögren's dry eye patients.
    Zang S; Cui Y; Cui Y; Fei W
    Eye (Lond); 2018 Nov; 32(11):1681-1687. PubMed ID: 29934634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of Thermal Pulsation Treatment for Dry Eye Syndrome in Patients With Sjogren Disease.
    Godin MR; Stinnett SS; Gupta PK
    Cornea; 2018 Sep; 37(9):1155-1158. PubMed ID: 29708939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between quantitative measurements of tear film lipid layer thickness and meibomian gland loss in patients with obstructive meibomian gland dysfunction and normal controls.
    Eom Y; Lee JS; Kang SY; Kim HM; Song JS
    Am J Ophthalmol; 2013 Jun; 155(6):1104-1110.e2. PubMed ID: 23465270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meibomian gland dysfunction in patients with Sjögren syndrome.
    Shimazaki J; Goto E; Ono M; Shimmura S; Tsubota K
    Ophthalmology; 1998 Aug; 105(8):1485-8. PubMed ID: 9709762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen deficiency, Meibomian gland dysfunction, and evaporative dry eye.
    Sullivan DA; Sullivan BD; Evans JE; Schirra F; Yamagami H; Liu M; Richards SM; Suzuki T; Schaumberg DA; Sullivan RM; Dana MR
    Ann N Y Acad Sci; 2002 Jun; 966():211-22. PubMed ID: 12114274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automated Measurement of Tear Film Dynamics and Lipid Layer Thickness for Assessment of Non-Sjögren Dry Eye Syndrome With Meibomian Gland Dysfunction.
    Ji YW; Lee J; Lee H; Seo KY; Kim EK; Kim TI
    Cornea; 2017 Feb; 36(2):176-182. PubMed ID: 28060064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is complete androgen insensitivity syndrome associated with alterations in the meibomian gland and ocular surface?
    Cermak JM; Krenzer KL; Sullivan RM; Dana MR; Sullivan DA
    Cornea; 2003 Aug; 22(6):516-21. PubMed ID: 12883343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A new approach for better comprehension of diseases of the ocular surface].
    Baudouin C
    J Fr Ophtalmol; 2007 Mar; 30(3):239-46. PubMed ID: 17417148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between systemic activity ındex and dry eye severity in patients with primary Sjögren syndrome.
    Ozek D; Kemer OE; Omma A
    Arq Bras Oftalmol; 2019; 82(1):45-50. PubMed ID: 30403265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of ocular surface status and function in primary Sjögren's syndrome with hypothyroidism].
    Yu HZ; Zeng WZ; Wu WY; Yao ZQ; Feng Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 54(4):705-711. PubMed ID: 35950396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tear Lysozyme in Sjögren´s syndrome, Meibomian gland dysfunction, and non-dry-eye.
    Berra M; Galperín G; Berra F; Marquez MI; Mandaradoni M; Tau J; Berra A
    Arq Bras Oftalmol; 2021; 85(2):103-108. PubMed ID: 34431892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical characteristics of patients with dry eye syndrome].
    Zhang M; Chen JQ; Liu ZG; Lou LH; Xiao QG; Yao Y; Chen LS; Zhang ZH
    Zhonghua Yan Ke Za Zhi; 2003 Jan; 39(1):5-9. PubMed ID: 12760805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Objective optical assessment of tear-film quality dynamics in patients with meibomian gland dysfunction and aqueous-deficient dry eye optical quality changes in different dry eye subtypes.
    Ye F; Jiang F; Lu Y; Xue CY; Zhu XM; Wu Y; Huang ZP
    Indian J Ophthalmol; 2019 May; 67(5):599-603. PubMed ID: 31007216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A standardized visual scale for evaluation of tear fluorescein clearance.
    Macri A; Rolando M; Pflugfelder S
    Ophthalmology; 2000 Jul; 107(7):1338-43. PubMed ID: 10889108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the Tear Meniscus by Strip Meniscometry and Keratograph in Patients With Dry Eye Disease According to the Presence of Meibomian Gland Dysfunction.
    Lee KW; Kim JY; Chin HS; Seo KY; Kim TI; Jung JW
    Cornea; 2017 Feb; 36(2):189-195. PubMed ID: 28060066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and content validity assessment of the Dry Eye Disease Questionnaire in patients with dry eye disease, meibomian gland dysfunction, and Sjögren's syndrome dry eye disease.
    Sloesen B; Young A; Forde K; Hodson N; Bentley S; Walsh O; Naujoks C; O'Brien P; Sharma G
    J Patient Rep Outcomes; 2023 Jul; 7(1):64. PubMed ID: 37405617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.